EX-12.1 5 d298302dex121.htm STATEMENT OF COMPUTATION OF RATIOS Statement of Computation of Ratios

EXHIBIT 12.1

Halozyme Therapeutics, Inc.

Statement of Computation of Ratios

 

                                   Nine  Months
Ended
September  30,
2011		  
            
   Year Ended December 31,    
     2006     2007     2008     2009     2010    
     (in thousands)  

Earnings:

             

Net loss

    $ (14,752 )    $ (23,896 )    $ (48,654 )    $ (58,361 )    $ (53,242 )    $ (1,354 ) 

Add: Fixed charges

      45        160        207        207        232        166   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

  

Earnings as defined

    $ (14,707 )    $ (23,736 )    $ (48,447 )    $ (58,154 )    $ (53,010 )    $ (1,188 ) 
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

  

Fixed Charges and Preferred Stock Dividends:

             

Interest expense

    $ —        $ —        $ —        $ 2      $ —        $ —     

Estimated interest component of rent expenses

      45        160        207        205        232        166   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

  

Total fixed charges

      45        160        207        207        232        166   

Preferred stock dividends

      —          —          —          —          —          —     
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

  

Total fixed charges and preferred stock dividends

    $ 45      $ 160      $ 207      $ 207      $ 232      $ 166   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

  

Ratio of earnings to fixed charges (1)

      —          —          —          —          —          —     
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

  

Ratio of earnings to combined fixed charges and preferred stock dividends (1)

      —          —          —          —          —          —     
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

  

 

(1) We reported a net loss for the years ended December 31, 2006, 2007, 2008, 2009, 2010 and the nine months ended September 30, 2011 and would have needed to generate additional income of approximately $14.8 million, $23.9 million, $48.7 million, $58.4 million, $53.2 million and $1.4 million respectively, to cover our fixed charges and combined fixed charges and preferred stock dividends of approximately $45,000, $160,000, $207,000, $207,000, $232,000 and $166,000, respectively.